denosumab
amgen,daiichi sankyo
['denosumab']
 drug holid w denosumab not recommended - rapid bone loss, incr bone markers
- incr risk of multiple vert fractures
- do not stop without replacing w alt rx dental work + denosumab: 4-5 mos post-rx
#acr22 #acrambassador
(pronounced VUH-neet sun-dhoo) Mother. She/Her/Hers. Rheumatologist. Program Director @lluhealth. Tweets are not medical advice. #ACRAmbassador @lluhphysicians